Dr. Doreen Rosenstrauch

powered by
COS Expertise®
University of Texas Health Science Center at Houston
Medical School
Internal Medicine
Cardiology
Assistant ProfessorAppointed: 2003
Rice University
George R. Brown School of Engineering
Bioengineering
Adjunct Assistant ProfessorAppointed: 2004
University of Houston
Cullen College of Engineering
Biomedical Engineering
Adjunct Assistant ProfessorAppointed: 2004
Texas Heart Institute at St. Luke's Episcopal Hospital
Cardiovascular Research
Research ScientistAppointed: 1998
Professional Headshot of Doreen  Rosenstrauch

Mailing Address

Texas Heart Institute at St. Luke's Episcopal Hospital
6770 Bertner Avenue
MC 2-225
Houston, Texas 77030
United States

Contact Information

Phone: (832) 355-3633
Fax: (832) 355-9368
Doreen.Rosenstrauch@Uth.Tmc.Edu
http://www.linkedin.com/in/drdoro

Qualifications

Ph.D. (magna cum laude), University of Texas Health Science Center at Houston/ Texas Heart Institute, and German Heart Center Berlin, Charite at the Humboldt University, 2004.
FAHA, Elected as an inaugural fellow of the American Heart Association, 2002.
M.D., Otto von Guericke University, 1997.
R.N., Humboldt University, 1991.

Expertise and Research Interests

Dr. Rosenstrauch is Prinicipal Investigator for studies on (1) Gene therapy and tissue engineering, (2) Development of coronary artery stents, (3) Dichloroacetate improves left ventricular function in isolated mammalian hearts, and (4) Auricular chondrocytes genetically engineered with E-NOS.

She is Co-Investigator for studies on Hypothermic ischemic arrest

Other Expertise

Dr. Rosenstrauch is Director of International Cooperation and Board Member of the Tanzania Heart Institute.

The Tanzania Heart Institute is registered and incorporated in the State of Texas, USA as a non-profit organization and is tax-exempt under the Internal Revenue Code Section 501 (C) (3). It is located in Dar-Es-Salaam, Tanzania and serves over 60 million people with the only heart surgical program in East Africa. The institute provides health services to children and adults who currently have no treatment opportunity. The Tanzania Heart Institute promotes especially prevention and treatment of cardiovascular disease as well as provides primary health care through its services, research, and education.

http://www.TanzaniaHeartInstitute.Org

Keywords

COS Keywords:

Bioengineering, Biomedical Engineering, Cardiology, Gene Therapy, Health of Underserved Populations, Ischemia, Organ Transplantation, Osteoarthritis, Preventive Medicine, Thoracic or Cardiovascular Surgery, Tissue Engineering.

Additional Terms:

Auricular Chondrocytes, Biocompatibility, Left Ventricular Assist Device.

Languages

(Reading, Writing, Speaking)

English: (Fluent, Fluent, Fluent)
German: (Fluent, Fluent, Fluent)
Russian: (Functional, Functional, Functional)
Latin: (Functional, Functional, Basic)
Spanish: (None, None, Basic)

Memberships

American Association for the Advancement of Science
American Heart Association
Association of Women Faculty at the University of Texas Health Science Center at Houston
International Society for Heart and Lung Transplantation

Honors and Awards

2004, Invited consultant of the Gerson Lehrman Group's Council of Healthcare Advisors,
2004Invited Biographee, WhoÂ’sWho in Medicine and Healthcare, Marquis, 5th Edition 2004-2005
2003, Invited member of the Reviewers Panel for The Center for the Biology of Chronic Disease, Dr. Hanan Polansky,Rochester, NY, USA., http://www.biologyofchronicdisease.org
2002, Visiting and Honorary Professor of the Tanzania Heart Institute Dar-es-Salaam, Tanzania, Tanzania Heart Institute
2002, F.A.H.A. Elected as an inaugural Fellow of the American Heart Association, American Heart Association
2002, International Reviewers Panel for the Medical Science Monitor http://www.MedSciMonit.com
2001, Honorary Professor (Profesora distinguida), Asociacion Mexicana de la Ciencia de los Animals de Laboratorio (AMCAL), Mexico

Funding Received

  • Roderick MacDonald Research Fellowship: Improving left ventricular function of isolated adult mammalian hearts, $50,000, Jul 2001 to Jun 2002.
  • Roderick MacDonald Research Fellowship: Improving left ventricular function of isolated adult mammalian hearts, $50,000, Jul 2000 to Jun 2001.
  • Collaborative Research: Drs. D.Rosenstrauch (THI,UTHSC), S.Canic (UH), C.Hartley (Baylor College of Medicine): Modeling the growth and adhesion of auricular chondrocytes under controlled flow conditions, $1,108,347, 2005 to 2009.
  • Roderick MacDonald Research Fund at St. Luke's Episcopal Hospital, Collaboartion between David Paniagua, MD, David Fish, MD, Doreen Rosenstrauch, MD: Cell Adhesion to Heterologous Biological Membranes to improve their Biocompatibility, $50,000, 2004 to 2005.
  • National Institutes of Health (NIH): Technologies for Monitoring & Performing Hypothermic Resuscitation, $300,000, 2004 to 2005.
  • Roderick Duncan MacDonald Research Fund at St. LukeÂ’s Episcopal Hospital: Auricular Chondrocytes Genetically Engineered with Endothelial Nitric Oxide Synthase, $49,995.95, 2003 to 2005.
  • National Science Foundation (NSF): Optimizing Stent Design, Research Experiences for Undergraduates program, NSF Division of Mathematical Sciences number: 9970310.Collaboration between the University of Houston and University of Texas Health Science Center/ Texas Heart Insitute, $100,000, 2003 to 2005.

Publications

  • S. Canic, J. Tambaca, A. Mikelic, CJ. Hartley,D. Mirkovic, J. Chavez and D. Rosenstrauch., "Blood flow through axially symmetric sections of compliant vessels: new effective closed models", Proceedings of the 26th Annual Engineering Conference IEEE Engineering in Medicine and Biology Society (EMBS), 15 Jun 2004
  • Doreen Rosenstrauch, MD, Harnath Shelat, BS, K. Ravi-Chandar, PhD, Marie Ng, Boniface Magesa, Arash Tadbiri, MD, David Paniaqua, MD, David Fish, MD, Suncica Canic, PhD, OH Frazier, MD, Coating stents with chondrocytes and genetically engineering of auricular chondrocytes, American Association for the Advancement of Science, 16 Feb 2004
  • Rosenstrauch, D., Kadipasaoglu, K., Shelath, H., Zoldhelyi, P., and Frazier, OH., 'Auricular Cartilage Tissue Engineering' in Tissue Engineering and Novel Delivery Systems, Yaszemski, Trantolo, Lewandrowski, Hasirci, Altobelli, and Wise (eds.), Marcel Dekker,Inc., New York, chapter 12, 253-264, November 2003
  • Abraham Quezada, Doreen Rosenstrauch, Marlene Leonard, Michael Coleman., Safety of Retrograde Venous Infusion of an HDel-1 Plasmid- Based Gene Medicine in a Swine Model, Medical Science Monitor., in review, July 2003
  • Doreen Rosenstrauch, RN, MD, Hakan Akay, MD, Hakki Bölükoglu, MD, Lars Behrens, Laura Bryant, BS, Peter Herrera, BS, Kazuhiro Eya, MD, Egemen Tuzun, MD, Fred Clubb, jr. DVM, PhD, Branislav Radovancevic, MD, O.H. Frazier, MD, Kamuran A. Kadipasaoglu, PhD, Ex Vivo Resuscitation of Adult Pig Hearts, Texas Heart Institute Journal, 30(2), 121-7, June 2003
  • Scott-Burden T, Bosley JP, Rosenstrauch D, Henderson KD, Clubb FJ Jr, Eichstaedt HC, Eya K, Gregoric I, Myers TJ, Radovancevic B, Frazier OH, Use of autologous auricular chondrocytes for lining artificial surfaces: a feasibility study, The Annals of Thoracic Surgery, 73(5), 1528-33, May 2002 Abstract
  • J.P. Bosley, K.D. Henderson, D. Rosenstrauch, R. Nichols, F.J. Clubb Jr., T. Scott-Burden, An Alternative Cell Type for Cardiovascular Linings: Auricular Chondrocytes, Biomedical Engineering Research, 4.4, 75, February 2000
  • Herrera P, Rosenstrauch D, Akay H, Inman R, Beyer E, Frazier OH, Radovancevic B, Kadipasaoglu K, Ex-vivo resuscitation of porcine hearts, ASAIO Journal, 46(2), 166, 2000
  • D Rosenstrauch, T Scott-Burden, OH Frazier, The Use of Tissue Engineering to Improve the Biocompatibility of the Left Ventricular Assist Device, The Journal of Heart and Lung Transplantation, 19(1), 59, Jan 2000
  • Boehm AK, Reinheckel T, Rosenstrauch D, Halangk W, Schulz HU, Screening for a point mutation of cationic trypsinogen in patients with pancreatic diseases, Digestion, 60, 369, July 1999
  • Bosley JP, Rosenstrauch D, Scott-Burden T, Genetic engineering of vascular cells to enhance cellular adhesion on cardiovascular devices, ASAIO Journal, 45(2), Spring 1999

Profile Details

Last Verified: 5/12/2008

COS Expertise ID #1095375
Reference this profile directly: http://myprofile.cos.com/drosenstrauch